Ritlecitinib, an innovative kinase inhibitor, is specifically designed for adults and adolescents aged 12 years and older to effectively treat severe alopecia areata.
Ritlecitinib is an innovative kinase inhibitor with precise target action, clear indication range, specific dosage and adverse reactions to be noted, which together constitute a comprehensive the...
Ritlecitinib is an innovative oral kinase inhibitor that offers a new treatment option for patients with severe alopecia areata. This article will start from the instructions of Ritlecitinib ...